Current Challenges in the Management of Vitreoretinal Conditions: 2nd Edition
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Ophthalmology".
Deadline for manuscript submissions: 31 December 2024 | Viewed by 1157
Special Issue Editor
2. Division of Ophthalmology and Visual Sciences, School of Medicine, University of Nottingham, Nottingham NG7 2UH, UK
Interests: ophthalmology; retina; vitreoretinal surgery; medical retina; molecular biology in ophthalmology; ocular pharmacology; ophthalmic surgery; biomarkers
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
In the ever-evolving landscape of Ophthalmology, the pursuit of excellence in understanding and managing eye diseases continues to push the boundaries of medical and surgical retina. Building upon the foundation laid by the first volume, we are proud to announce the call for submissions for the 2nd Edition of our Special Issue titled "Current Challenges in the Management of Vitreoretinal Conditions”(https://www.mdpi.com/journal/jcm/special_issues/vitreoretinal_conditions).
This Special Issue will delve deeper into the latest advancements and explore emerging challenges in the treatment and surgical intervention of vitreoretinal diseases. We aim to encapsulate the cutting-edge developments and innovative research that have emerged since our last volume, focusing on the enhancement of patient care and treatment outcomes for conditions such as age-related macular degeneration, diabetic retinopathy, retinal detachment, and more.
We invite high-quality original research studies, both clinical and experimental, that contribute to our growing understanding of these complex conditions. Comprehensive review articles that synthesize recent advancements, propose new treatment paradigms, or evaluate the long-term outcomes of novel therapies are also welcome. Additionally, we continue to recognize the impact of global health challenges, such as the COVID-19 pandemic, on the management of vitreoretinal diseases and encourage submissions that address these topics.
Potential topics include, but are not limited to, the following:
- Innovations in the medical and surgical management of vitreoretinal diseases;
- Advances in anti-VEGF therapies and the development of new drug delivery systems;
- Novel diagnostic and imaging techniques in the assessment of vitreoretinal conditions;
- The role of genetics and personalized medicine in treating retinal and vitreoretinal disorders;
- The influence of telemedicine and digital health technologies on patient care and management;
- Comprehensive strategies for managing the complex cases of retinal detachment, macular holes, and epiretinal membranes;
- The evaluations of the socio-economic impacts on the accessibility and quality of vitreoretinal care;
- Insights into the management of uveitis and ocular inflammations in the modern era.
We believe that this 2nd Edition will be an essential addition to the collective knowledge in the field, offering a platform for sharing groundbreaking research and fostering discussions that will shape the future of vitreoretinal medicine.
We look forward to receiving your contributions.
Dr. Georgios D. Panos
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- retina
- anti-VEGF
- implants
- macular degeneration
- diabetic retinopathy
- vein occlusions
- retinal detachments
- vit-reoretinal surgery
- COVID-19 impact
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
